C. Wolf-Peeters

发表

Detection of Immunoglobulin κ Light Chain Rearrangements by Polymerase Chain Reaction: An Improved Method for Detecting Clonal B-Cell Lymphoproliferative Disorders

G. Inghirami, G. Palestro, R. Chiarle, 1999 .

Plasmacytoid Monocytes in Jessner's Lymphocytic Infiltration of the Skin

H. Degreef, F. Facchetti, V. Desmet, 1990, The American Journal of dermatopathology.

Technical Advance Detection of Immunoglobulin k Light Chain Rearrangements by Polymerase Chain Reaction An Improved Method for Detecting Clonal B-Cell Lymphoproliferative Disorders

G. Inghirami, G. Palestro, R. Chiarle, 1999 .

Immunophenotypic analysis of histiocytes involved in AIDS‐associated Mycobacterium scrofulaceum infection: similarities with lepromatous lepra

J. Delabie, V. Desmet, G. Bilbe, 1991, Clinical and experimental immunology.

Histiocytes in Sweet's syndrome

J. Delabie, V. Desmet, C. Wolf‐peeters, 1991, The British journal of dermatology.

The B 7 / BB 1 Antigen Is Expressed by Reed-Sternberg Cells of Hodgkin ’ s Disease and Contributes to the Stimulating Capacity of Hodgkin ’ s Disease-Derived Cell Lines

J. Delabie, J. Ceuppens, P. Vandenberghe, 2003 .

Histiocyte‐Rich B‐Cell Lymphoma: A Distinct Clinicopathologic Entity Possibly Related to Lymphocyte Predominant Hodgkin's Disease, Paragranuloma Subtype

J. Delabie, C. Kennes, M. Stul, 1992, The American journal of surgical pathology.

[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?

Patrick Dupont, Jan Balzarini, Guy Bormans, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion.

J. Delabie, P. Vandenberghe, A. Tierens, 1999, Blood.

Expression of B7-2 (CD86) molecules by Reed–Sternberg cells of Hodgkin’s disease

J. Delabie, J. Ceuppens, P. Vandenberghe, 1997, Leukemia.

Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal‐binding proteins and show a bi‐activated phenotype

R. Gascoyne, C. Steidl, R. Küppers, 2013, International journal of cancer.

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

H Stein, B Falini, P M Banks, 1994, Blood.

Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances.

J. Delabie, A. Hagemeijer, C. de Wolf‐Peeters, 2001, Blood.

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.

P. Dupont, L. Mortelmans, G. Verhoef, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling

C. de Wolf‐Peeters, G. Verhoef, D. Dierickx, 2006, The Journal of pathology.

Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

M Chilosi, M. Pagano, A. Montagnoli, 2000, Blood.

"Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis.

S. Pittaluga, C. Mecucci, C. de Wolf‐Peeters, 1996, The American journal of surgical pathology.

Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation.

A. Hagenbeek, S. Pittaluga, C. de Wolf‐Peeters, 1996, Blood.

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18f]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma : Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

P. Dupont, L. Mortelmans, G. Bormans, 2001 .

Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.

C. de Wolf‐Peeters, R. Achten, A. Carbone, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Mantle-cell lymphoma.

S. Pittaluga, C. de Wolf‐Peeters, C. Wolf-Peeters, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma.

R. Gascoyne, H. Müller-Hermelink, D. Jong, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.

S. Pittaluga, A. Scarpa, H. Yee, 1996, Blood.

T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity.

L. Vanuytsel, R. Achten, G. Verhoef, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

P. Dupont, L. Mortelmans, G. Bormans, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Restrictive dermopathy with distinct morphological abnormalities.

C. de Wolf‐Peeters, J. Fryns, E. Legius, 1990, American journal of medical genetics.

Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities

P. de Paepe, C. de Wolf‐Peeters, C. Wolf-Peeters, 2007, Leukemia.

Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis.

V. Desmet, J. J. van den Oord, C. de Wolf‐Peeters, 1989, Human pathology.

Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis.

A. Hagemeijer, R. Sciot, C. de Wolf‐Peeters, 2002, The American journal of surgical pathology.